Nasus Pharma Ltd. is a clinical-stage specialty pharmaceutical company based in Tel Aviv-Yafo, Israel, that specializes in developing innovative intranasal drug formulations for critical emergency medical conditions. Leveraging its proprietary drug delivery technology, the company seeks to enhance treatment efficacy and patient compliance, particularly in urgent care scenarios. With a strong pipeline of products in development, Nasus Pharma is poised to become a leader in the rapidly evolving intranasal therapeutics market, emphasizing patient-centric solutions and improved healthcare outcomes. The company's strategic focus on innovation positions it to address significant unmet medical needs, making it an attractive opportunity for institutional investors.